news archive genetic news - September 17, 2003

September 17, 2003

your information resource in human molecular genetics

-	Avigen Cleared to Resume Clinical Trial of Hemophilia B Treatment FDA, Children’s Hospital of Philadelphia and Stanford University Medical Center Approve Resumption.
-	Merck and Alnylam Establish Industry's First Strategic Alliance to Apply RNA Interference for Human Therapeutics Merck and Alnylam will work collaboratively to advance RNAi technology and jointly apply the technology to develop RNAi-based therapeutics that selectively target human diseases.